LAIC
CLB icon

Lederer & Associates Investment Counsel’s Core Laboratories CLB Stock Holding History

Lederer & Associates Investment Counsel’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-225
Closed -$6.48K – 98
2021
Q1 		$6.48K Buy
+225
New +$7.69K ﹤0.01% 142
2015
Q3 		$405K Sell
4,060
-100
-2% -$10.9K 0.45% 56
2015
Q2 		$474K Sell
4,160
-40
-1% -$4.85K 0.49% 50
2015
Q1 		$439K Sell
4,200
-315
-7% -$33.6K 0.43% 56
2014
Q4 		$543K Buy
+4,515
New +$593K 0.54% 51

Other funds holding CLB

FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lederer & Associates Investment Counsel's CLB Position: Q2 2021 in Review

Lederer & Associates Investment Counsel sold out of Core Laboratories (CLB) in Q2 2021, closing a stake of 225 shares — an estimated $6.48K sold.

Lederer & Associates Investment Counsel first reported a position in CLB in Q4 2014 and held it in 5 quarters. The position peaked at $543K in Q4 2014. 195 funds tracked by Wall St. Rank hold CLB as of Q2 2021.

  • Lederer & Associates Investment Counsel reported no remaining Core Laboratories position as of Q2 2021 after selling out during the quarter.
  • Lederer & Associates Investment Counsel sold 225 Core Laboratories shares in Q2 2021, an estimated $6.48K.
  • Lederer & Associates Investment Counsel first reported a position in Core Laboratories in Q4 2014 and held it in 5 quarters.
  • Lederer & Associates Investment Counsel's Core Laboratories position peaked at $543K in Q4 2014.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2021.

Based on Lederer & Associates Investment Counsel's 13F filing for Q2 2021, filed 23 Jul 2021.